Subcutaneous epcoritamab with rituximab + lenalidomide (R(2)) in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): Update from phase 1/2 trial Meeting Abstract
| Authors: | Falchi, L.; Leppä, S.; Wahlin, B. E.; Nijland, M.; Christensen, J. H.; De Vos, S.; Holte, H.; Linton, K. M.; Abbas, A.; Wang, L.; Dinh, M.; Elliott, B.; Belada, D. |
| Abstract Title: | Subcutaneous epcoritamab with rituximab + lenalidomide (R(2)) in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): Update from phase 1/2 trial |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301985 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.7524 |
| Notes: | Meeting Abstract: 7524 -- This meeting was also held virtually -- Source: Wos |
